
Exhibit 4.17 EXECUTION COPY SUPPLY AGREEMENT FERRER INTERNACIONAL, S.A. AND CUTANEA LIFE SCIENCES, INC. [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUPPLY AGREEMENT This Supply Agreement (the "Agreement") is  made  as of this ____  day  of  March ,  2018  (the "Effective  Date  "), by and between Cutanea Life Sciences, Inc., a corporation duly  organized  and  existing  under the laws of the State of Delaware with its principal place of business at  1500  Liberty Ridge Drive, Suite 3000, Wayne, PA 19087 hereinafter  referred  to as "CUTANEA"), and Ferrer Internacional, S.A., a Spanish corporation with its principal place of business at Av. Diagonal, 549, 5t h floor, 08029 Barcelona (Spain) (hereinafter indistinctly  referred  to as "Ferrer" and/or "Supplier"). CUTANEA and Ferrer  taken  together hereinafter are  referred  to as "PARTIES". WITNESSETH: WHEREAS, CUTANEA is  engaged  in the distribution, promotion and sale of certain pharmaceutical, OTC and medical device products and in particular desires that Ferrer manufacture (directly and/or through a third party) and  supply  CUTANEA with the "Products" (as  defined  below); and WHEREAS, Ferrer and Medimetriks Pharmaceuticals, Inc. (hereinafter "Medimetriks")  entered  into a License and Supply Agreement  dated   March 10, 2014 , as  amended  , (hereinafter  referred  as "LSA") pursuant to which among other things, Ferrer  granted  Medimetriks exclusive commercialization and distribution rights to the Product (as  defined  in the LSA) throughout the Territory (as  defined  in the LSA); and WHEREAS, with Ferrer's consent, CUTANEA has  acquired  and  assumed  the rights, duties and obligations of Medimetriks under the LSA; and WHEREAS, Ferrer  desires  to  manufacture  (directly and/or through a third party) and  supply  CUTANEA with such Products; NOW, THEREFORE, in consideration of the mutual covenants hereinafter  expressed  , the Parties,  intending  to be legally  bound  hereby,  agree  as  follows  : 1. DEFINITIONS 1.1 Act "Act" means the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated hereunder. 1.2 Business Day "Business Day" means any  day  other than a  Saturday ,  Sunday  or other  day  on which banks in Philadelphia, Pennsylvania and/ or Barcelona, Spain are permitted or required to close by any applicable law. [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 1.3 Confidential Information "Confidential Information" means, other than information described in Section 9.1.2, all business and technical information, including third party information, in whatever form or manner presented, which is: (a) disclosed by or on behalf of a party (the "Disclosing Party") to the other party (the "Receiving Party") or learned or observed by the Receiving Party before or during the  term  of this Agreement; and (b) disclosed during any discussions and proceedings relating to any of the foregoing information, whether disclosed in oral, electronic, visual, written or any other form. "Confidential Information" shall  include  all information of the Disclosing Party that the Disclosing Party would  consider  confidential or proprietary under the circumstances. The fact that the Disclosing Party may have  marked  or  identified  as confidential or proprietary any specific information shall be indicative that such Disclosing Party  believes  such information to be confidential or proprietary, but the failure to so  mark  information shall not  determine  that such information is or is not  considered  confidential information by such Disclosing Party. 1.4 FDA "FDA" means the United States Food and Drug Administration, or any successor entity thereto. 1.5 Forecasted Needs "Forecasted Needs" means CUTANEA's estimate of Products (including in trade/sample form) to be ordered from Supplier for the upcoming rolling [***] period. 1.6 Governmental or Regulatory Authority "Governmental or Regulatory Authority" means governments, regulatory authorities, governmental departments, agencies, agents, commissions, bureaus, officials, courts, bodies, boards, tribunals or dispute settlement panels or other law, rule or regulation-making organizations or entities (a) having or purporting to have jurisdiction on behalf of any nation, territory or state or any other geographic or political subdivision of any of them, or (b) exercising, or entitled or purporting to exercise any administrative, executive, judicial, legislative, policy, regulatory or taxing authority or power. 1.7 Manufacture "Manufacture" means all the activities relating to production of the Products including packaging and shipment preparation, quality control and release of Products. All the references  contained  in this Agreement  regarding  manufacturing activities shall be  deemed   rendered  by Supplier, even if  performed  by its designee (whether in the form of a subcontractor, agent or otherwise). In consequence, all Manufacturing activities with respect to the Products to be  Manufactured  hereunder by Supplier shall be  carried  out by Supplier (or its designee) at the  notified  facility and  utilizing  equipment in the manner set forth in the Specifications, except to the extent that Supplier  receives  CUTANEA's advance  written  permission to  alter  the location or  specified  usage of the equipment that may be  required  under the Specifications or the NDA, as applicable. 3 [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 1.8 Product(s) "Product(s)" means product(s) as listed from time to time in Schedule A Manufactured by the Supplier (directly or through a third person) to meet the Specifications (as hereinafter defined); except as otherwise set forth on Schedule A, the Product will be ready for re-sale by CUTANEA to its customers in finished, final packaged form bearing CUTANEA's labels, it being understood that, after generic competition of the Product enters the market in the United States of America including Puerto Rico and the U.S. Virgin Islands, CUTANEA will be permitted to place orders for Product under a generic label. The  term  "Generic" shall be  interpreted  as  defined  under Section 1.17 of the LSA. 1.9 Specifications "Specifications" means, with respect to the Products, the critical quality standards that include test attributes, analytical procedures, and appropriate acceptance criteria and Manufacturing procedures for which such Product should conform to be considered acceptable for its intended use and conform to quality standards approved by Governmental and Regulatory Authorities and as provided in the NDA for the Products, and required for the Manufacture and supply of such Product(s). 1.10 Supply Price "Supply Price" means the price to be charged to CUTANEA from time to time by Supplier for Products Manufactured and supplied hereunder, as set forth in Schedule A. 2. PRODUCT MANUFACTURE AND SUPPLY 2.1 Manufacture and Purchase. Subject to the terms and conditions of this Agreement, Supplier  agrees  that it will, on a non-exclusive basis (but exclusive for supply of the Product in the United States of America  including  Puerto Rico and the U.S. Virgin Islands), Manufacture (directly or through a designee) for and  provide  and  supply  to CUTANEA, and CUTANEA  agrees  that it will  purchase  exclusively from Supplier, all of its requirements of the Products as  follows  : Supplier shall  supply  Products in accordance with the Specifications and in sufficient quantity to  meet  CUTANEA's Forecasted Needs for the length of this Agreement. All deviations from the Specifications must be  approved  by CUTANEA, in writing, prior to Supplier Manufacturing the Product. 2.2 Raw Materials and Components. As between Supplier and CUTANEA, Supplier shall be responsible for the supply of all raw materials and components necessary for the Manufacture of Products at no additional cost to CUTANEA. Supplier (or its designee) shall  order  the initial components for each Product as soon as CUTANEA  provides  Supplier (or its designee) with the relevant artwork for the Product. 4 [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 2.3 Quality Tests and Checks. In order to  assure  the conformity of the Products to the Specifications, the Supplier shall  deliver  or  cause  to be  delivered  to CUTANEA, at the time of shipment, a certificate of analysis and compliance or other batch documentation upon reasonable request (such as, deviations, investigations, batch records) with respect to each batch of Product  supplied  hereunder in the form  required  by the Quality Agreement. 2.4 Forecasting and Other Obligations. 2.4.1 As soon as practicable  following  execution of this Agreement, but in any event within ten (10) Business Days, CUTANEA  agrees  to  provide  Supplier with a best estimate, non-binding (except for the first  six months ) forecast of its Forecasted Needs for Products ( including  in trade/sample form) for the upcoming rolling  18-month period  (the "Forecast"). Thereafter, CUTANEA will  update  this  rolling  [***]  Forecast  quarterly. 2.4.2 With regards to the FDA Fees, CUTANEA shall  maintain  the NDA for the Products and  pay  , from time to time, all  required  FDA filing and related Product fees. 2.4.3 CUTANEA shall  notify  Supplier within one Business Day, after it  receives  any materially adverse contact or communication from any Governmental or Regulatory Authority that  relates  to any Product. Supplier shall  notify  CUTANEA as soon as reasonably possible after it  receives  any materially adverse contact or communication from any Governmental or Regulatory Authority that  relates  to any Product and may reasonably be  expected  to  affect  patient safety. For matters that would not reasonably be  expected  to  affect  patient safety, Supplier shall  notify  CUTANEA of such communications in its discretion. 2.4.4 CUTANEA shall  provide  Supplier with copies of all communications  received  from or  sent  to any Governmental or Regulatory Authority with respect to any Product within three business  days  after receipt or  sending  of the communication, as the case may be (subject to confidentiality and privilege restrictions, if any). CUTANEA shall  consult  with Supplier  regarding  the response to any inquiry or observation from a Governmental or Regulatory Authority  relating  to a Product. CUTANEA shall  consider  all reasonable requests and comments by Supplier with respect to all contacts and communications with a Governmental or Regulatory Authority. 2.5 Purchase Orders. 2.5.1 CUTANEA  agrees  to  purchase  from Supplier all Products  Manufactured  for CUTANEA in accordance with valid CUTANEA Purchase Orders pursuant to the terms of this Agreement and  provided  that such Products  meet  the Specifications  approved  by CUTANEA. 5 [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 2.5.2 During the  term  of this Agreement, CUTANEA will  order  Product(s) by  issuing  firm Purchase Orders not less than [***] business  days  before the  requested  delivery date(s) of such Product(s), and Supplier shall  provide  approval of the Purchase Order by the Supplier within five (5) business  days   following  the Purchase Order reception, such approval  signifying  Supplier's commitment to  deliver  such Product(s) on the requested deliver date(s), it being  understood  that Supplier must  accept  a Purchase Order for delivery of Product not less than [***] business  days  before the  requested  delivery date when  included  in the first [***] of the Forecasted Needs. Each purchase order shall set forth the Product for which the purchase order is being  issued  , the quantity being  ordered  (in trade/sample form), the Supply Price for the Product(s) being  ordered  and the  requested  delivery date for the Product being  ordered  , and the locations to which such quantities shall be  delivered  . 2.5.3 Within ten (10) Business Days  following  this Agreement  becoming  effective and thereafter on or before  the last day  of each calendar quarter, CUTANEA shall  provide  Supplier with specific data as to its Forecasted Needs for such Product ( including  in trade/sample form) for the  following  rolling [***]. Supplier will  use  commercially reasonable efforts to  deliver  Product to  CUTANEA  with minimum expiry dating  remaining  of [***]% of the  approved  shelf-life. 2.5.4 CUTANEA's purchase orders shall  designate  the  desired  quantities of Products, delivery dates and destinations. Supplier shall  fill  and  ship  all orders of Products in accordance with CUTANEA's reasonable written instructions. CUTANEA'S purchase order may  specify  up to three (3) shipping destinations per batch of Product but will be in full pallet quantities. Additional destinations can be  accommodated  only upon CUTANEA payment of a shipping preparation fee to be  negotiated  by Supplier and CUTANEA. 2.6 Acceptance / Rejection of Products. 2.6.1 All Products shall be  submitted  to inspection and evaluation by or on behalf of CUTANEA to  determine  whether or not  said  Products  meet  the Specifications. CUTANEA will  provide  in good faith  written  acceptance of a batch of Product or  written  notification of any deficiencies within two (2) Business Days after receipt of the Certificate of Analysis for the Product batch.  Written  acceptance of a batch of the applicable Product is  required  as a condition to the delivery of Product to Cutanea's  designated   shipping  agent in accordance with Section 3. If for any reason Supplier  does  not  receive  any such notification within such two (2) Business Day period, Supplier will promptly  notify  CUTANEA of such fact and CUTANEA will as soon as practicable and, in any event within another two (2) Business Days thereafter  provide  such  written  notice to Supplier and be responsible for any storage or similar charges that Supplier may  incur  for not  delivering  such Product. The lack of reception of such  written  acceptance within the second two (2) Business Day period shall be  deemed  as the batch is  accepted  . If, once the Product is  delivered  , CUTANEA  determines  that there is any deficiency with respect to any Product, CUTANEA will  notify  Ferrer of such claim within fifteen (15) Business Days of delivery of the Products. Each such notice of rejection to Supplier shall  specify  in reasonable detail the ways in which the Product batch  failed  to  meet  Specifications. CUTANEA shall  grant  to Supplier (or its designee) the right to  inspect  or  test   said  Product batch and  dispute  CUTANEA rejection  according  to the provisions  provided  in this Section 2.6. In the event that Supplier  disagrees  with CUTANEA's defective Product claim, the issue shall be  submitted  to a mutually  agreed  upon independent third party laboratory, whose decision shall be final and  binding  upon the Parties. The costs  arising  from the laboratory's intervention and the costs of the  replaced  Products ( including  return and destruction costs of the defective Products) shall be  borne  by the Party whose results were  mistaken  . As to any such Product batch which is determined to  fail  the Specifications ("Rejected Product"), CUTANEA shall have no obligation to  pay  for such Rejected Product and Supplier shall  replace  such Rejected Product  as soon as possible  and no later than ninety (90)  days  thereafter. 6 [***] = CERTAIN CONFIDENTIAL  INFORMATION  CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS,  HAS   BEEN   OMITTED  BECAUSE THE INFORMATION (I)  IS  NOT MATERIAL AND (II) WOULD  BE  COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 2.6.2 In the event of a conflict between the test results of Supplier and the test results of CUTANEA with respect to any shipment of Product batch, within thirty (30)  days   following  receipt by Supplier of CUTANEA's notice of rejection, sample of such Product batch shall be  submitted  by Supplier (and/or its nominee) to an independent laboratory  designated  by Supplier (and/or its nominee) and reasonably acceptable to CUTANEA, which shall  perform  an assessment and whose findings shall be conclusive.
